Home › Neoplasie del sangue › Minnesota › Minneapolis
Studi clinici su Neoplasie del sangue a Minneapolis, MN
11 studi su Neoplasie del sangue cercano partecipanti presso sedi a Minneapolis e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · a 5 mi di distanza
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
In reclutamentoStudio osservazionale
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Minneapolis VA Medical Center, Minneapolis
- e altri 1
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
In reclutamentoFase 3
- University of Minnesota, Minneapolis
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
In reclutamentoFase 2
- University of Minnesota, Minneapolis
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
In reclutamento
- Masonic Cancer Center, University of Minnesota, Minneapolis
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
In reclutamentoFase 2
- University of Minnesota Masonic Cancer Center, Minneapolis
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
In reclutamentoFase 1
- University of Minnesota, Minneapolis
CIBMTR Research Database
In reclutamentoStudio osservazionale
- Center for International Blood and Marrow Transplant Research, Minneapolis
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
In reclutamentoFase 1/2
- University of Minnesota, Minneapolis
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
In reclutamentoFase 1
- University of Minnesota, Minneapolis
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
In reclutamentoFase 1
- Children's Hospital and Clinics of Minnesota, Minneapolis
Studi su Neoplasie del sangue in altre città
- Houston, TX46 studi
- New York City, NY26 studi
- Boston, MA25 studi
- Washington, DC19 studi
- Baltimore, MD18 studi
- Seattle, WA18 studi
- Los Angeles, CA17 studi
- Durham, NC16 studi
- Chicago, IL15 studi
- Philadelphia, PA14 studi
- Atlanta, GA13 studi
- Nashville, TN13 studi
Altri studi a Minneapolis
- Cancro al seno27 studi
- Cancro del polmone non a piccole cellule26 studi
- Cancro ovarico24 studi
- Cancro alla prostata23 studi
- Cancro (tutti i tipi)22 studi
- Insufficienza cardiaca21 studi
- Cancro ai polmoni20 studi
- Leucemia mieloide acuta20 studi
- Cancro colorettale19 studi
- Cancro dell'endometrio18 studi
- Morbo di Parkinson17 studi
- Malattie cardiovascolari15 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.